BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 2781294)

  • 1. Postponement of satiety by blockade of brain cholecystokinin (CCK-B) receptors.
    Dourish CT; Rycroft W; Iversen SD
    Science; 1989 Sep; 245(4925):1509-11. PubMed ID: 2781294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCK antagonists and CCK-monoamine interactions in the control of satiety.
    Cooper SJ; Dourish CT; Clifton PG
    Am J Clin Nutr; 1992 Jan; 55(1 Suppl):291S-295S. PubMed ID: 1728842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Satiety induced by endogenous and exogenous cholecystokinin is mediated by CCK-A receptors in mice.
    Weatherford SC; Chiruzzo FY; Laughton WB
    Am J Physiol; 1992 Apr; 262(4 Pt 2):R574-8. PubMed ID: 1566921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endogenous cholecystokinin reduces feeding in young rats.
    Weller A; Smith GP; Gibbs J
    Science; 1990 Mar; 247(4950):1589-91. PubMed ID: 2321020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous CCK and the peripheral neural substrates of intestinal satiety.
    Ritter RC; Brenner LA; Tamura CS
    Ann N Y Acad Sci; 1994 Mar; 713():255-67. PubMed ID: 8185167
    [No Abstract]   [Full Text] [Related]  

  • 6. Multiple cholecystokinin (CCK) receptors and CCK-monoamine interactions are instrumental in the control of feeding.
    Cooper SJ; Dourish CT
    Physiol Behav; 1990 Dec; 48(6):849-57. PubMed ID: 1982361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for an involvement of the brain cholecystokinin B receptor in anxiety.
    Singh L; Lewis AS; Field MJ; Hughes J; Woodruff GN
    Proc Natl Acad Sci U S A; 1991 Feb; 88(4):1130-3. PubMed ID: 1996314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholecystokinin-A receptor mediation of food intake in cats.
    Bado A; Durieux C; Moizo L; Roques BP; Lewin MJ
    Am J Physiol; 1991 Apr; 260(4 Pt 2):R693-7. PubMed ID: 2012242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type-A CCK receptors mediate the inhibition of food intake and activity by CCK-8 in 9- to 12-day-old rat pups.
    Smith GP; Tyrka A; Gibbs J
    Pharmacol Biochem Behav; 1991 Jan; 38(1):207-10. PubMed ID: 2017446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracerebroventricular cholecystokinin A-receptor antagonist does not reduce satiation by endogenous CCK.
    Brenner LA; Ritter RC
    Physiol Behav; 1998 Feb; 63(4):711-6. PubMed ID: 9523920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2-Naphthalenesulphanyl-L-aspartyl-2-(phenethyl) amide (2-NAP) and food intake in rats: evidence that endogenous peripheral CCK does not play a major role as a satiety factor.
    Ebenezer IS; Baldwin BA
    Br J Pharmacol; 1995 Nov; 116(5):2371-4. PubMed ID: 8581271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of type A, not type B, CCK receptors attenuates satiety actions of exogenous and endogenous CCK.
    Moran TH; Ameglio PJ; Schwartz GJ; McHugh PR
    Am J Physiol; 1992 Jan; 262(1 Pt 2):R46-50. PubMed ID: 1733339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The CCK-A receptor antagonist devazepide but not the CCK-B receptor antagonist L-365,260 reverses the effects of chronic clozapine and haloperidol on midbrain dopamine neurons.
    Minabe Y; Ashby CR; Wang RY
    Brain Res; 1991 May; 549(1):151-4. PubMed ID: 1893248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of BIM-18216, a novel cholecystokinin receptor antagonist, on food intake reduction induced by cholecystokinin.
    Laferrere B; Nguyen M; Bonhomme G; Legall A; Basdevant A; Guy-Grand B
    Behav Neurosci; 1991 Oct; 105(5):707-11. PubMed ID: 1815620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Centrally administered cholecystokinin suppresses feeding through a peripheral-type receptor mechanism.
    Crawley JN; Fiske SM; Durieux C; Derrien M; Roques BP
    J Pharmacol Exp Ther; 1991 Jun; 257(3):1076-80. PubMed ID: 2046021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholecystokinin octapeptide analogues suppress food intake via central CCK-A receptors in mice.
    Hirosue Y; Inui A; Teranishi A; Miura M; Nakajima M; Okita M; Nakajima Y; Himori N; Baba S; Kasuga M
    Am J Physiol; 1993 Sep; 265(3 Pt 2):R481-6. PubMed ID: 8214137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SCH 23390-induced hypophagia is blocked by the selective CCK-A receptor antagonist devazepide, but not by the CCK-B/gastrin receptor antagonist L-365,260.
    Cooper SJ; Barber DJ
    Brain Res Bull; 1990 Apr; 24(4):631-3. PubMed ID: 2141538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral factors in the mediation of cholecystokinin-induced satiety as assessed by comparative potencies of cholecystokinin antagonists.
    Murphy RB; Smith GP; Schneider LH; Gibbs J
    Peptides; 1992; 13(1):77-81. PubMed ID: 1620660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockade of type A, but not type B, CCK receptors postpones satiety in rhesus monkeys.
    Moran TH; Ameglio PJ; Peyton HJ; Schwartz GJ; McHugh PR
    Am J Physiol; 1993 Sep; 265(3 Pt 2):R620-4. PubMed ID: 8214156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for an endogenous cholecystokininergic balance in social memory.
    Lemaire M; Piot O; Roques BP; Böhme GA; Blanchard JC
    Neuroreport; 1992 Oct; 3(10):929-32. PubMed ID: 1421101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.